Last reviewed · How we verify
NCT03499977: ACE
Acute Cycling on Executive Control
NA trial testing Sitting in Physical Activity in 20 participants. Completed in 31 July 2019.
31 December 2018
Quick facts
| Lead sponsor | Western University, Canada |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 1 July 2018 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 July 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Sitting
- Light-Intensity Cycling
- Moderate-Intensity Cycling
- High-Intensity Cycling
Conditions studied
- Physical Activity — all drugs for Physical Activity →
Sponsor
Western University, Canada
Who can join
Adults 18 to 64, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will examine whether 10-minute bouts of cycling at various intensities will impact executive functioning (i.e., cognitive ability) as assessed by the antisaccade (AS) task through a total of five visits. An antisaccade is a rapid eye movement away from a visual target. The ability to suppress making an eye movement towards a visual target gauges inhibitory control (i.e., a domain of executive functioning). In the initial visit, participants' exercise capacity will be assessed through a maximal effort cycling test. Intensities for the cycling bouts (i.e., high, moderate, low) in subsequent sessions will be based upon this maximal effort cycling test. In visits 2 through 5, participants will complete an AS task, followed by a 10-minute bout of cycling, and then complete the AS task again. The order of cycling intensities will be randomized between participants. Differences in the AS task (i.e., reaction time and accuracy) will be compared between and within cycling conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03499977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sitting
Trials testing the same drug.
- NCT05203731 — Level of Physical Activity and Fear Learning · NA · completed
- NCT04298710 — Effects of Arm Cycling and Leg Cycling on Postprandial Blood Glucose Levels in Healthy Persons · NA · terminated
- NCT03944564 — Cognitive and Motor Benefits of Standing · NA · unknown
- NCT04389736 — Effects of NMES on Energy Expenditure, Glycaemia and Hormonal Responses to Glucose Ingestion · NA · completed
- NCT03213717 — Effect of Body Weight Loading on Urinary Electrolyte Excretion · NA · completed
Other recruiting trials for Physical Activity
Currently open trials in the same condition.
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
- NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
- NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting
Other Western University, Canada trials
Trials by the same sponsor.
- NCT07485062 — Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes · Phase 4 · not yet recruiting
- NCT07372755 — Feasibility and Usability of a Mobile App for Monitoring and Managing Functional Movement Disorders · not yet recruiting
- NCT07302308 — Action Outcome Latencies as a Measure of Sense of Agency in Functional Movement Disorders. · not yet recruiting
- NCT04323423 — The DURATION Study: reDUcing sedentaRy behAviour to Maintain cogniTIve functiON. · NA · withdrawn
- NCT07204301 — Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Pat · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03499977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Western University, Canada
- Last refreshed: 6 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03499977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing